Not Yet Recruiting
A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants
NCT07549750
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Veritus Research Bayswater, Victoria, Australia